Yayın:
The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases

Placeholder

Tarih

Akademik Birimler

Kurum Yazarları

Eker, Salih Saygın
Sarandol, Aslı
Akkaya, Cengiz
Sivrioğlu, Enver Yusuf
Kırlı, Selçuk

Yazarlar

Danışman

Dil

Türü

Yayıncı:

Sage Publications

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Özet

QTc interval prolongation may appear as a consequence of both typical and atypical antipsychotic treatments. Ziprasidone, which is effective in treating schizophrenia, is associated with QTc prolongation. Although the prolongation of QTc with ziprasidone treatment is often pronounced, there is a scarce number of cases reported about the relationship between ziprasidone and QTc prolongation. Of the three cases presented in this case series, two cases showed values exceeding 0.50 s with ziprasidone treatment.

Açıklama

Kaynak:

Anahtar Kelimeler:

Konusu

Antipsychotic, QTc prolongation, Ziprasidone, Torsade-de-pointes, Schizoaffective disorder, Antipsychotic-drugs, Acute exacerbation, Double-blind, 160 mg/day, Schizophrenia, Safety, Haloperidol, Management, Neurosciences & neurology, Pharmacology & pharmacy, Psychiatry

Alıntı

Eker, S. S. vd. (2009). "The potential relationship between QTc interval prolongation and ziprasidone treatment: Three cases". Journal of Psychopharmacology, 23(8), 993-996.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads